Hi Prophet4me,
Looking back at 2012 it's share price was cheap/wrong below 0.90 and ridiculous below 0.80 cents. Hence a takeover offer 10 days after it fell below 60 cents.
Then, I would have accepted $1.50 and been happy given the risks and outlook. I suspect the company would have too.
Everything is different now. YES I think it is very possible now. Much more compelling at $1.90+
At Iron Ore 'average' of $US107 for FY15 and FY16 and no currency movement, ARI EPS = 22 cents. P/E = 4.5
Reuters FY15 EPS = 19.6 (14 analysts average)
So at $1.90 is only a P/E = 10
EV/EBIT = 6.5 (market is at 10!) 50% higher
This is the most applicable metric and more useful than P/E
So a bargain at $1.90, is what I am saying.
Book Value = $2.85 so if you take it over at $1.90 you instantly make an accounting profit of 50% on the transaction.
The currency is 10% lower now than Sept 2012 which makes it 10% more attractive!
Iron ore Spot has only ever traded for 14 days now since spot started below $US100.
- Forums
- ASX - By Stock
- ARI
- takeover potential
ARI
arika resources limited
Add to My Watchlist
0.00%
!
3.7¢

takeover potential, page-3
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
3.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $28.96M |
Open | High | Low | Value | Volume |
3.6¢ | 3.7¢ | 3.6¢ | $68.65K | 1.897M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 298501 | 3.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.7¢ | 161297 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 298501 | 0.036 |
2 | 2600000 | 0.035 |
3 | 531911 | 0.034 |
3 | 1628212 | 0.033 |
6 | 848986 | 0.032 |
Price($) | Vol. | No. |
---|---|---|
0.037 | 161297 | 1 |
0.039 | 250000 | 1 |
0.040 | 400000 | 1 |
0.041 | 314750 | 2 |
0.042 | 356348 | 4 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
ARI (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online